Concepedia
Statistics
Publications
27
Citations
1.2K
H-Index
22
Active since
2014
Affiliations
Ghent University(Current)
Ghent University Hospital
Cancer Research Institute Ghent
KU Leuven
Inserm
Wouter Van Loocke is an author at Ghent University specializing in molecular oncology, life sciences, and molecular biology.
Publications per year
2014–2023
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste et al. · Nature Communications · 2018 · 111 citations · Full text
Life Sciences, Genetics, Molecular Genetics +17
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
Niels Vandamme, Geertrui Denecker, Kenneth Bruneel et al. · Cancer Research · 2020 · 89 citations
Medicine, Molecular Biology, Oncology +17
The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation
Sylvie Taveirne, Sigrid Wahlen, Wouter Van Loocke et al. · Blood · 2020 · 74 citations · Full text
Life Sciences, Developmental Biology, Molecular Biology +11
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
Sofie Peirs, Viktoras Frismantas, Filip Matthijssens et al. · Leukemia · 2017 · 69 citations
Medicine, Oncology, Pharmacology +12
GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate
Inge Van de Walle, Anne‐Catherine Dolens, Kaat Durinck et al. · Nature Communications · 2016 · 66 citations · Full text
Life Sciences, Cell Biology, Immunology +17
1–5 of 27